Ocugen, Inc. (OCGN)
1.30
+0.07
(+5.69%)
USD |
NASDAQ |
Dec 11, 16:00
1.30
0.00 (0.00%)
After-Hours: 20:00
Ocugen Cash from Investing (Quarterly): -0.086M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Belite Bio, Inc. | -- |
| MannKind Corp. | -25.06M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
| CorMedix, Inc. | -291.32M |
| Verastem, Inc. | -8.279M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.92M |
| Cash from Financing (Quarterly) | 18.51M |
| Free Cash Flow | -53.53M |
| Free Cash Flow Per Share (Quarterly) | -0.0428 |
| Free Cash Flow to Equity (Quarterly) | -13.15M |
| Free Cash Flow to Firm (Quarterly) | -11.69M |
| Free Cash Flow Yield | -13.97% |